Certest Biotec, established in Spain in 2002 as an innovative and technology-based company, has always based its growth on the research and development of new products, and the exploration for new market niches and opportunities. The key to understand its success is the way to understand its organization: highly specialized and customer oriented. Certest Pharma part of Certest Biotec, is dedicated to building a platform for the development of RNA vaccines and oligotherapeutics, with a special focus on seeking improved formulations to enhance delivery. In that sense, Certest Pharma is specialized in the development of raw materials, amongst which lipids and more specifically, ionizable lipids, are one of the leading products. Certest´s Pharma three main areas are: Delivery technology: Ionizable lipids are a key element in the production of lipid nanoparticles (LNPs), and as such, have been widely used for the systemic delivery of RNA therapeutics. After the screening of more than a thousand ionizable lipids with our semi-rational design we are able to offer outperforming and custom made ionizable lipids for the effective targeted delivery of RNA therapeutics. API platform: This platform will cover, thanks to over 20 years of experience in the field, all the necessary steps for the design, development, and evaluation of effective mRNA and oligotherapeutics molecules. Also, a proprietary UTR sequence and codon optimization software have been developed showing higher results in protein expression. Enzymes for the production of mRNA have also been developed. Therapeutic products: Bringing together both areas Certest was granted to develop a new booster for TB vaccine and therefore be able to show the full capabilities of the company.
Centre for Virology, Vaccinology and Therapeutics
The Centre for Virology, Vaccinology, and Therapeutics (CVVT), established in 2020 with the University of Hong Kong, is dedicated to reducing the health and economic impacts of future outbreaks. By pioneering rapid diagnostics, potent antimicrobials, and advanced vaccines, CVVT tackles endemic diseases in peacetime and prepares the world for epidemics and pandemics. Serving as a crucial bridge between foundational research and transformative technologies, CVVT cultivates a dynamic startup ecosystem focused on innovative solutions for infectious diseases and global health advancements. At this exhibition, discover our innovative startups: • Orimmune BioTech Limited, introducing its revolutionary Δ42PD1-specific antibody drug, set to redefine cancer immunotherapy with a novel immune-modulatory approach. • Antenovus Biotechnology Limited, combating antimicrobial resistance (AMR) with antivirulence therapies and antibiotic adjuvants targeting pathogens like MRSA. • Hong Kong Universal Vaccine Limited, unveiling its next-generation inhaled powder vaccine for children and elderly, offering needle-free mucosal immunity against influenza, COVID, and RSV. • BiomOrgan Limited, showcasing the world’s first human respiratory organoid culture system, transforming drug development and virus research. Visit our booth to explore how CVVT converts visionary research into practical solutions, enhancing global health resilience and positioning Hong Kong as a biotechnology hub against emerging infectious threats.
BIOPROFARMA BAGO
For more than 15 years Bioprofarma Bagó has been positioned as a laboratory specialized in high-complex treatments with different therapeutical areas and with a wide-range portfolio of health care products. To be part of Bagó Group, with its development, strength and prestige, endorses our new identity. Our history begins in 2003, when Bagó Group became interested in cancer and biotechnology areas. Since that moment, and aiming to offer therapeutic solutions with proven efficacy and quality, our company has been expanding and improving its portfolio with new molecules in order to enlarge the physicians´ treatment decisions for their patients. Currently we have 56 products and 88 approved presentations, which are registered in Argentina, and many of them are also approved by the regulatory agencies in Latin America, Southeast Asia and French speaking Africa. Our portfolio is mainly focused on Hematology, Oncology, Urology, Neurology and Rare Diseases. Besides the products developed in our own laboratory, we have received licenses of multinational companies which have entrusted us the promotion and distribution of their products in Argentina. Focused on being a leader company in medicines for special pathologies in the region, we have recently finished the construction of a new pharmaceutical plant in Argentina. This plant will have two specialized production lines: one for injectable medications (both liquid and lyophilized), and the other one for the development of solid oral products. This new plant will be among the most modern of the country, in compliance not only with the ANMAT standards, but also with the most demanding regulatory authorities in the region. Our purpose is to expand our current exports far beyond our 17 destinations and to reach new territories. We are completely aware that behind each medicine that Bioprofarma Bagó supplies to the market, there is a hope of recovery and an improvement for the quality of a person´s life. This awareness, that demands and commits us to the whole society, is the inspiration and the motivation for meeting better therapeutical alternatives. The importance we give to ensure quality, in compliance with good manufacturing practices, was and will be our basis as a company. Bioprofarma Bagó grows, evolves and is transformed to go beyond the limits of science through safe, efficient and innovative solutions. The constant evolution identifies us and makes us unique.
BIOCLONAL
BioClonal is a Spanish biotech company enabling immune responses against disease targets that were previously considered out of reach. Founded in 2022 and based in Zaragoza, BioClonal has developed a proprietary platform that unlocks the generation of high-affinity monoclonal antibodies and antigen-specific immune responses, even against the most complex or poorly immunogenic targets. Our technology can be applied in both therapeutic antibody development and next-generation vaccines, offering a versatile solution for tackling diseases with high unmet medical need. We are currently advancing a first-in-class antibody candidate for Alzheimer’s disease and are open to R&D collaborations, co-development, and licensing partnerships. BioClonal operates from its own labs and is actively engaging with pharma, biotech, and academic partners to expand the reach of its discovery engine.
BIO Business Solutions®
BIO Business Solutions is the largest cost-savings purchasing program for the life sciences industry, operated by BIO. We pool the purchasing power of thousands of life sciences companies to negotiate for exclusive pricing and favorable terms on business-critical products, like lab supplies, regulatory services, HR and much more. BIO helped 4,700 life science companies save over $705 million last year alone. | BIO Business Solutions is the largest cost-savings program for the life sciences industry, operated by BIO. We pool the purchasing power of thousands of life science companies to negotiate for exclusive pricing and favorable terms on business-critical products, like lab supplies, cleanroom services, HR and much more. Every year, BIO helps nearly 5,000 companies save over $700 million. | BIO Business Solutions is the largest cost savings program for the life sciences industry, operated by BIO. BIO Business Solutions negotiates significant volume-based discounts, favorable terms, and other benefits on products and services with industry leading suppliers on behalf of BIO members and the members of state and regional biotech associations. Learn more at bio.org/save.
Arochi & Lindner
Arochi & Lindner: Premier Legal Solutions for the Life Sciences and Pharmaceutical Industries With more than 30 years of experience, Arochi & Lindner is a leading law firm in Mexico and Spain, known for its excellence in Intellectual Property, Litigation, and Regulatory Advisory. Our Life Sciences practice stands out as one of the most robust in the market, providing strategic legal solutions for companies in the pharmaceutical, biotechnology, medical device, food, cosmetics, and agricultural sectors. We recognize that the Life Sciences sector is constantly evolving and encounters complex regulatory challenges. That’s why we offer thorough legal counsel that covers a wide range of services, including trademark and patent registration, obtaining sanitary authorizations from COFEPRIS, drafting licensing agreements, ensuring regulatory compliance, handling patent litigation, and navigating public procurement processes. Our multidisciplinary team — which includes attorneys, chemists, engineers, and biotechnologists — combines technical and legal expertise to provide practical and efficient solutions aligned with our clients’ business goals. We have successfully represented drug companies in high-profile patent disputes and have managed groundbreaking innovations, such as the first microorganism deposit at Mexico’s National Center for Genetic Resources (CNRG). At Arochi & Lindner, we don’t just protect innovation — we empower it. Our mission is to act as a strategic partner for companies transforming health, technology, and quality of life through science.
Argentina Pavilion
Argentina export promotion agency | . | Agencia Argentina de Inversiones y Comercio Exterior
Apotex Latin America HQ
Apotex is a Canadian based global health company, A Force for Health with a mission to improve everyday access to affordable, innovative medicines and health products for patients and consumers worldwide. Apotex aims to continue developing its positioning as the ideal partner of choice in the Americas – with a very strong presence in North America (Canada, USA, Mexico), and an ongoing geographic expansion towards Central America and South America. As a Canadian company, we strive for excellence and patient impact, and are willing to partner with leading pharmaceutical companies to drive patient access across the entire Latin American region. From our headquarters in Mexico City, our team is capable to develop unique value propositions, which leverages our industrial footprint locally, with one of the largets API manufacturing facilities in the continent, as well as a large finished-good production facility, on top of medical promotion focused on a variety of therapeutic areas for branded and branded generics products, and a fast-growing OTC / consumer health operation. https://apotex.com/global
AmbioPharm, Inc.
AmbioPharm is a global leader in peptide manufacturing, specializing in the development and production of peptide-based Active Pharmaceutical Ingredients (APIs). Founded in 2005 and headquartered in North Augusta, South Carolina, USA, we are a patient-focused Contract Development and Manufacturing Organization (CDMO) with a reputation for technical excellence, innovation, and cost-effective solutions. Our state-of-the-art facilities in South Carolina, USA, and Shanghai, China, manufacture New Chemical Entities (NCEs) and peptide APIs under cGMP compliance, supporting pharmaceutical and biotech clients worldwide. AmbioPharm provides comprehensive peptide manufacturing solutions that support our clients from early-stage development through full-scale commercial production. Our expertise covers solid-phase, solution-phase, and hybrid synthesis, as well as organic conjugations to proteins, toxoids, antifungals, KLH (Keyhole Limpet Hemocyanin), and PEG (Polyethylene Glycol). We offer end-to-end peptide development services, including scale-up, validation, and process qualification leading up to New Drug Application (NDA) submissions with the U.S. Food and Drug Administration (FDA). With our advanced manufacturing facilities, robust quality systems, and cost-effective approach, AmbioPharm is the trusted partner for pharmaceutical and biotech companies seeking high-quality peptide APIs for both clinical and commercial applications. | AmbioPharm is a global peptide CDMO founded in 2005 and headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at clinical and commercial stages. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA as well as other global regulatory bodies with excellent outcomes. Our mission is to accelerate your peptides to patients.
ALLTRISTA PLASTICS
Alltrista Plastics LLC specializes in innovative, high-volume, precision manufacturing for the medical, consumer packaging, and high-end industrial markets. With five locations worldwide, we use proprietary engineering processes and extensive manufacturing capabilities to design innovations the world needs now. From the first spark of an idea, through the design of the mold, to the actual manufactured product, we focus all efforts on creating superior solutions for our customers. This foundation gives us the incredible ability to integrate material science, machine, and automation manufacturing technologies for exceptional results. Pushing the boundaries of sustainable solutions for our customers are our core team of employees who live out our Alltrista values each and every day: Count on Me, Play to Win, and Positively Impacting Lives. Come join our family. | Alltrista’s innovations are everywhere. We make a variety of solutions for pharmaceutical, consumer health, and industrial applications, including high-quality medicine bottles and certified child-resistant caps that give parents peace of mind. Building on deep experience, Alltrista’s material scientists listen to our clients’ needs to quickly and constantly refine and optimize the tools of the trade. Our unique ability to rally strong teams around projects allows us to be agile with even the most demanding tasks. We reimagine manufacturing processes to give our clients unprecedented solutions. This is what makes Alltrista’s products and partnerships exceptional, and what keeps our clients coming back. This is how we make a material difference every day. | At Alltrista, we want to help bring your ideas to life from concept through commercialization. Our goal is to optimize and innovate across every industry and provde the service that you need for your product. We offer a cohesive lineup of stock rigid packaging products and services related to design, tooling & automation, cleanroom manufacturing, injection molding, compression blow forming, automated assembly, filling and kit packing across a variety of industries.